Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMD14 | O00487 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
| ▸ | TOP2A | P11388 | 1/20 | 0.30 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14397335 | 0.67 | — | — | |
| SCHEMBL3066557 | 0.63 | CA2 (0.67) | PSMD14CA2TSHRKDM4E | |
| SCHEMBL16824544 | 0.62 | — | — | |
| SCHEMBL29167393 | 0.60 | ALDH1A1 (0.43) | TSHR | |
| SCHEMBL2761339 | 0.59 | — | — | |
| SCHEMBL5658359 | 0.59 | — | — | |
| SCHEMBL10833048 | 0.58 | MAP2K1 (0.45) | TSHRHTT | |
| SCHEMBL11373401 | 0.55 | HSD17B10 (0.50) | TSHRKDM4EHTTTOP2ASLC22A12 | |
| SCHEMBL6279062 | 0.55 | — | — | |
| Bicarbonate SCHEMBL9560502 | 0.53 | IDUA (0.41) | CA2TSHRKDM4EHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1712 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11779896-B2 | Magnetic-optical composite nanostructure | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2023-10-10 | — | — | US | claimed |
| EP-3514177-B1 | ANTIBODY SPECIFICALLY BINDING TO PD-1 AND FUNCTIONAL FRAGMENT THEREOF | Beijing hanmi pharm co ltd (CN) | 2023-07-26 | — | — | EP | claimed |
| US-20230201380-A1 | NON-INVASIVE AND LONGITUDINAL MONITORING OF MICROGLIAL ACTIVATION IN RAT BRAIN WITH SUPERMAGNETIC NANOPARTICLE ENHANCED MR IMAGING | UNM RAINFOREST INNOVATIONS (US) | 2023-06-29 | — | — | US | claimed |
| CN-109627338-B | Novel anti-human PD-L1 antibody and application thereof | 苏州药明泽康生物科技有限公司 | 2022-10-18 | — | — | CN | claimed |
| US-20220146431-A1 | REAGENTS AND METHODS FOR DETECTING INFECTIOUS DISEASES | IONICA SCIENCES | 2022-05-12 | — | — | US | claimed |
| EP-3514176-B1 | ANTIBODY SPECIFICALLY BINDING TO IL-17A AND FUNCTIONAL FRAGMENT THEREOF | BEIJING HANMI PHARMACEUTICAL CO LTD (CN) | 2021-12-15 | — | — | EP | claimed |
| WO-2021242896-A1 | NON-INVASIVE AND LONGITUDINAL MONITORING OF MICROGLIAL ACTIVATION IN RAT BRAIN WITH SUPERMAGNETIC NANOPARTICLE ENHANCED MR IMAGING | UNM RAINFOREST INNOVATIONS (US) | 2021-12-02 | — | — | WO | claimed |
| EP-3875599-A1 | METHODS FOR DETECTION OF RARE SUBPOPULATIONS OF CELLS AND HIGHLY PURIFIED COMPOSITIONS OF CELLS | Astellas Institute for Regenerative Medicine (US) | 2021-09-08 | — | — | EP | claimed |
| CN-110483643-B | Novel antibody composition, isolated nucleic acid and preparation method | 深圳市雅为泓源生物科技有限公司 | 2021-06-08 | — | — | CN | claimed |
| EP-2596119-B1 | METHODS FOR DETECTION OF RARE SUBPOPULATIONS OF CELLS AND HIGHLY PURIFIED COMPOSITIONS OF CELLS | ASTELLAS INST FOR REGENERATIVE MEDICINE (US) | 2021-04-28 | — | — | EP | claimed |
| US-6855503-B2 | Heterocyclic FRETdye cassettes for labeling biological molecules and their use in DNA sequencing | AMERSHAM BIOSCIENCES CORP (US) | 2005-02-15 | — | — | US | claimed |
| WO-2004059011-A1 | HETEROCYCLIC FRET DYE CASSETTES FOR LABELING BIOLOGICAL MOLECULES AND THEIR USE IN DNA SEQUENCING | AMERSHAM BIOSCIENCES CORP (US) | 2004-07-15 | — | — | WO | claimed |
| US-20040126763-A1 | Heterocyclic FRETdye cassettes for labeling biological molecules and their use in DNA sequencing | GE HEALTHCARE BIO-SCIENCES CORP. | 2004-07-01 | — | — | US | claimed |
| WO-2004029578-A2 | ENERGY TRANSFER DYES, TERMINATORS AND USE THEREOF | AMERSHAM BIOSCIENCES CORP (US) | 2004-04-08 | — | — | WO | claimed |
| WO-2004029579-A2 | FLUORESCENT LABELING REAGENTS WITH MULTIPLE DONORS AND ACCEPTORS | AMERSHAM BIOSCIENCES CORP (US) | 2004-04-08 | — | — | WO | claimed |
| JP-2002523783-A | — | — | 2002-07-30 | — | — | JP | claimed |
| EP-1110088-A1 | ENERGY TRANSFER DYES | Amersham Pharmacia Biotech Inc (US) | 2001-06-27 | — | — | EP | claimed |
| WO-2000013026-A9 | ENERGY TRANSFER DYES | AMERSHAM PHARM BIOTECH INC (US) | 2000-08-17 | — | — | WO | claimed |
| WO-2000013026-A1 | ENERGY TRANSFER DYES | AMERSHAM PHARMACIA BIOTECH, INC. (US) | 2000-03-09 | — | — | WO | claimed |
| US-5863727-A | AN ACCEPTOR FLUOROPHORE EFFICIENTLY ABSORBS ENERGY EMISSION OF A LINKED DONOR XANTHENE FLUOROPHORE LABELLING A OLIGONUCLEOTIDE PRIMER; REAGENT FOR SEQUENCING NUCLEIC ACIDS | THE PERKIN-ELMER CORPORATION | 1999-01-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040126763-A1 | Heterocyclic FRETdye cassettes for labeling biological molecules and their use in DNA sequencing | DNTT, POLL, POLRMT | PSMD14 2733/4885CA2 4796/4885TSHR 2059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.